DDAVP RHINYLE
FERRING INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is DDAVP RHINYLE discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that DDAVP RHINYLE 0.1MG has been permanently discontinued (last updated March 2, 2021). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
TEVA-DESMOPRESSIN
TEVA CANADA LIMITED
OCTOSTIM LIQ INJ. 15MCG/ML
FERRING INC
MINIRIN
FERRING INC
NU-DESMOPRESSIN SPRAY
NU-PHARM INC
DDAVP INJ 4MCG/ML
FERRING INC
DESMOPRESSIN TABLETS
RAINBOW PHARMACEUTICALS INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
00402516
Strength
0.1MG
Dosage Form
SOLUTION
Route
NASAL
Compare with another product →
Shortage History
Other Products from FERRING INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
75UNIT · DIN 02268140
10MG · DIN 02231047
9MG · DIN 02455889
4MCG · DIN 00873993
240MCG · DIN 02285010
120MCG · DIN 02285002
60MCG · DIN 02284995
10MCG · DIN 00836362
0.1MG · DIN 00824305
0.2MG · DIN 00824143
0.1MG · DIN 02389282
100MCG · DIN 02496526